Golden Age Health (GAH) is a fast-growing pharma platform dedicated to accelerating patient access to life-changing therapies for rare and specialty diseases in high-unmet-need markets. Led by former C-suite executives from Biogen, Merck, and other global leaders, we bridge the gap between proven innovators and the 2 billion people living in China, Asia and the Middle East.

What sets us apart
- Rare disease launch experience – Our team has done the most successful rare disease launches in China and Asia including Spinraza by Biogen.
- End-to-end commercialization – From dossier preparation to supply-chain management, omnichannel medical engagement, and real-world evidence generation, we own the entire value chain.
- Flexible deal structures – Up-front + milestone, distribution & promotion, profit-share, or JV—our models fit partners of every size.
- Data-driven execution – Real-world data and AI-powered analytics drive precise patient-finding, adherence programs, and pricing strategies.
- Pan-regional reach – One platform, three regions: mainland China + Hainan Pilot Zone, key ASEAN markets, and leading Gulf Cooperation Council (GCC) countries.

Biotechnology

Health Services

Golden Age Health

Org chart

Teams

Offices